Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_748d59b0cde9710523094becd0c1b701 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2300-0874 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2300-0681 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2300-163 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2400-0487 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0686 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0679 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L3-502746 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L3-502761 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0684 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5044 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M29-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M29-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M23-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M21-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M3-06 |
filingDate |
2018-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3080fa2aad3224ad33663cea68a0a680 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f14d603ede21b001031c312f4c0182a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_161b67e6d035cfcb8a2ece36df5912eb |
publicationDate |
2020-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2020392441-A1 |
titleOfInvention |
Novel microfluidic devices implementing blood and urine circuit for emulating homeostatic microphysiological system |
abstract |
The present disclosure relates to novel microfluidic devices and their use for operating microphysiological systems. The novel microfluidic devices are particularly useful for pharmacokinetic-pharmacodynamic analysis in the context of ADME(T) profiling. The present disclosure provides novel microfluidic devices comprising a first “blood” circuit with one or more cell culture compartments, and a second “urine” circuit comprising a renal filtration and reabsorption unit, wherein both circuits are connected with each other via the filtration unit and the reabsorption unit. The present disclosure further provides methods, kits and assays implementing the novel microfluidic devices. |
priorityDate |
2017-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |